精神疾病共病对类风湿关节炎患者医疗资源使用的影响:一项基于人群的研究
该研究基于1984-2016年行政健康数据,纳入12,984例类风湿关节炎(RA)患者并按年龄、性别和地区匹配64,510名对照,分析精神疾病共病(抑郁、焦虑、双相障碍、精神分裂症)对2006-2016年医疗资源使用的影响。结果显示,RA合并精神疾病共病者较单纯RA患者有协同增加的就诊次数、住院率、住院天数和药物种类,有效管理精神疾病共病或可减少RA患者的医疗资源使用。
要点
- RA合并精神疾病共病者就诊次数、住院率和住院天数呈协同增加。
- RA合并精神疾病共病者较单纯RA患者多领取6.85种药物(95%CI 6.43,7.27)。
- 有效管理精神疾病共病可能减少RA患者的医疗资源使用。
核心结论
- 在RA患者中,精神疾病共病与医疗资源使用的协同增加相关,有效管理精神疾病共病或可减少医疗资源使用。
研究设计与样本
- 基于行政健康数据(1984-2016)的基于人群的队列研究,纳入12,984例确诊RA患者,按年龄、性别和地区以1:5匹配64,510名对照。
- 在队列内识别精神疾病共病(抑郁、焦虑、双相障碍、精神分裂症),活跃精神疾病共病定义为每年≥2次就诊。
- 比较2006-2016年四组(对照、对照+精神疾病、RA、RA+精神疾病)的年度医疗资源使用率,使用广义线性模型调整年龄、性别、城乡居住、收入五分位和总共病数。
主要发现
- RA患者主要为女性(72%)和城市居民(59%),平均年龄54±16岁。
- 与无精神疾病共病的RA患者相比,RA合并精神疾病共病者有超过相加效应的就诊次数(SMD 10.92,95%CI 10.25,11.58)、住院率(SMD 13%,95%CI 0.11,0.14)和住院天数(SMD 3.63,95%CI 3.06,4.19)。
- RA合并精神疾病共病者较无精神疾病共病的RA患者多领取6.85种药物(95%CI 6.43,7.27)。
- RA合并精神疾病共病者增加了家庭医生就诊次数(额外SMD 8.92次,95%CI 8.35,9.46)。
- 在个体内模型中,精神疾病共病增加了医疗资源使用。
临床怎么用
- 在RA管理中应识别并有效管理精神疾病共病,可能有助于减少医疗资源使用。
- 对RA合并精神疾病共病者,需关注其家庭医生就诊、住院和多重用药的增加。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Psychiatric comorbidity is frequent in rheumatoid arthritis (RA) and complicates treatment. The present study was undertaken to describe the impact of psychiatric comorbidity on health care use (utilization) in RA. METHODS: We accessed administrative health data (1984-2016) and identified a prevalent cohort with diagnosed RA. Cases of RA (n = 12,984) were matched for age, sex, and region of residence with 5 controls (CNT) per case (n = 64,510). Within each cohort, we identified psychiatric morbidities (depression, anxiety, bipolar disorder, and schizophrenia [PSYC]), with active PSYC defined as ≥2 visits per year. For the years 2006-2016, annual rates of ambulatory care visits (mean ± SD per person) categorized by provider (family physician [FP], rheumatologist, psychiatrist, other specialist), hospitalization (% of cohort), days of hospitalization (mean ± SD), and dispensed drug types (mean ± SD per person) were compared among 4 groups (CNT, CNT plus PSYC, RA, and RA plus PSYC) using generalized linear models adjusted for age, sex, rural versus urban residence, income quintile, and total comorbidities. Estimated rates are reported with 95% confidence intervals (95% CIs). We tested within-person and RA-PSYC interaction effects. RESULTS: Subjects with RA were mainly female (72%) and urban residents (59%), with a mean ± SD age of 54 ± 16 years. Compared to RA without PSYC, RA with PSYC had more than additive (synergistic) visits (standardized mean difference [SMD] 10.92 [95% CI 10.25, 11.58]), hospitalizations (SMD 13% [95% CI 0.11, 0.14]), and hospital days (SMD 3.63 [95% CI 3.06, 4.19]) and were dispensed 6.85 more medication types (95% CI 6.43, 7.27). Cases of RA plus PSYC had increased visits to FPs (an additional SMD 8.92 [95% CI 8.35, 9.46] visits). PSYC increased utilization in within-person models. CONCLUSION: Managing psychiatric comorbidity effectively may reduce utilization in RA.
引用
- Hitchon CA, Walld R, Peschken CA, et al. Impact of Psychiatric Comorbidity on Health Care Use in Rheumatoid Arthritis: A Population-Based Study. Arthritis Care Res (Hoboken). 2021. PMID: 32702203. doi:10.1002/acr.24386
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。